ClinVar Miner

Submissions for variant NM_016239.4(MYO15A):c.5287C>T (p.Arg1763Trp)

gnomAD frequency: 0.00205  dbSNP: rs200146361
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000155191 SCV000204877 likely benign not specified 2017-01-13 criteria provided, single submitter clinical testing p.Arg1763Trp in exon 20 of MYO15A: This variant is not expected to have clinical significance because it has been identified in 0.6% (42/6614) of Finnish chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs200146361).
Illumina Laboratory Services, Illumina RCV001000460 SCV000401153 uncertain significance Autosomal recessive nonsyndromic hearing loss 3 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
CeGaT Center for Human Genetics Tuebingen RCV000487626 SCV000575094 likely benign not provided 2024-11-01 criteria provided, single submitter clinical testing MYO15A: BS1:Supporting
Labcorp Genetics (formerly Invitae), Labcorp RCV000487626 SCV001023230 likely benign not provided 2024-11-04 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001000460 SCV001157303 benign Autosomal recessive nonsyndromic hearing loss 3 2023-09-27 criteria provided, single submitter clinical testing
GeneDx RCV000487626 SCV001784308 likely benign not provided 2020-10-20 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 32860223, 30180840, 30245029, 24123792)
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000487626 SCV001956710 uncertain significance not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000487626 SCV001975921 uncertain significance not provided no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV003927505 SCV004739460 likely benign MYO15A-related disorder 2020-02-18 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.